| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 2.17e-06 | 12 | 44 | 3 | GO:0032396 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.14e-06 | 599 | 44 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 7.96e-06 | 18 | 44 | 3 | GO:0032393 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 4.73e-05 | 5 | 44 | 2 | GO:0030107 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 7.08e-05 | 6 | 44 | 2 | GO:0030109 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 9.54e-05 | 210 | 44 | 5 | GO:0019903 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 9.90e-05 | 7 | 44 | 2 | GO:0023025 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ANTXR1 EPOR AMHR2 OR8K3 TAS2R60 OR52L2P LILRB1 LILRB2 L1CAM LILRB4 LAG3 | 1.27e-04 | 1353 | 44 | 11 | GO:0004888 |
| GeneOntologyMolecularFunction | IgM binding | 2.58e-04 | 11 | 44 | 2 | GO:0001791 | |
| GeneOntologyMolecularFunction | phosphatase binding | 2.77e-04 | 264 | 44 | 5 | GO:0019902 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.83e-04 | 58 | 44 | 3 | GO:0042287 | |
| GeneOntologyMolecularFunction | alpha-catenin binding | 3.09e-04 | 12 | 44 | 2 | GO:0045294 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 3.09e-04 | 12 | 44 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | immune receptor activity | 4.72e-04 | 165 | 44 | 4 | GO:0140375 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 5.58e-04 | 16 | 44 | 2 | GO:0023029 | |
| GeneOntologyMolecularFunction | integrin binding | 5.89e-04 | 175 | 44 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 7.92e-04 | 19 | 44 | 2 | GO:0032394 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 9.70e-04 | 21 | 44 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.27e-03 | 24 | 44 | 2 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.61e-03 | 27 | 44 | 2 | GO:0008391 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.26e-03 | 32 | 44 | 2 | GO:0042288 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.34e-03 | 120 | 44 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 2.70e-03 | 35 | 44 | 2 | GO:0008157 | |
| GeneOntologyMolecularFunction | aromatase activity | 2.70e-03 | 35 | 44 | 2 | GO:0070330 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 2.85e-03 | 36 | 44 | 2 | GO:0019865 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 3.68e-03 | 41 | 44 | 2 | GO:0023023 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 5.23e-03 | 49 | 44 | 2 | GO:0016712 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.72e-03 | 749 | 44 | 6 | GO:0005509 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 5.87e-03 | 52 | 44 | 2 | GO:0042169 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated inhibitory signaling pathway | 8.42e-08 | 5 | 43 | 3 | GO:0002774 | |
| GeneOntologyBiologicalProcess | immune response-inhibiting cell surface receptor signaling pathway | 1.00e-06 | 10 | 43 | 3 | GO:0002767 | |
| GeneOntologyBiologicalProcess | immune response-inhibiting signal transduction | 1.83e-06 | 12 | 43 | 3 | GO:0002765 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 3.52e-06 | 50 | 43 | 4 | GO:0044331 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EFNB1 CDH1 CDH2 CDH3 LILRB1 LILRB2 TSPAN9 NOTCH4 L1CAM LILRB4 LAG3 | 9.19e-06 | 1077 | 43 | 11 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of T cell costimulation | 1.27e-05 | 3 | 43 | 2 | GO:2000524 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 1.31e-05 | 252 | 43 | 6 | GO:0022408 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 2.27e-05 | 580 | 43 | 8 | GO:0022407 | |
| GeneOntologyBiologicalProcess | plasmacytoid dendritic cell activation | 4.23e-05 | 5 | 43 | 2 | GO:0002270 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 8.34e-05 | 111 | 43 | 4 | GO:0002709 | |
| GeneOntologyBiologicalProcess | regulation of T cell costimulation | 8.86e-05 | 7 | 43 | 2 | GO:2000523 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 1.02e-04 | 927 | 43 | 9 | GO:0030155 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.17e-04 | 232 | 43 | 5 | GO:0002706 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 1.20e-04 | 375 | 43 | 6 | GO:0007162 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 1.45e-04 | 49 | 43 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 1.46e-04 | 389 | 43 | 6 | GO:0022409 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell tolerance induction | 1.51e-04 | 9 | 43 | 2 | GO:0002666 | |
| GeneOntologyBiologicalProcess | T cell costimulation | 1.64e-04 | 51 | 43 | 3 | GO:0031295 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | 1.72e-04 | 576 | 43 | 7 | GO:0002443 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 1.77e-04 | 579 | 43 | 7 | GO:0045785 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.84e-04 | 53 | 43 | 3 | GO:0016339 | |
| GeneOntologyBiologicalProcess | lymphocyte costimulation | 1.84e-04 | 53 | 43 | 3 | GO:0031294 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 1.94e-04 | 54 | 43 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | dendritic cell differentiation | 1.94e-04 | 54 | 43 | 3 | GO:0097028 | |
| GeneOntologyBiologicalProcess | interleukin-10-mediated signaling pathway | 2.31e-04 | 11 | 43 | 2 | GO:0140105 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 2.53e-04 | 59 | 43 | 3 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 2.73e-04 | 151 | 43 | 4 | GO:1902106 | |
| GeneOntologyBiologicalProcess | positive regulation of tolerance induction | 2.77e-04 | 12 | 43 | 2 | GO:0002645 | |
| GeneOntologyBiologicalProcess | adherens junction organization | 2.79e-04 | 61 | 43 | 3 | GO:0034332 | |
| GeneOntologyBiologicalProcess | leukocyte homeostasis | 2.87e-04 | 153 | 43 | 4 | GO:0001776 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 3.17e-04 | 449 | 43 | 6 | GO:0002449 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 3.32e-04 | 159 | 43 | 4 | GO:1903707 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 3.65e-04 | 163 | 43 | 4 | GO:0002456 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic depression | 3.80e-04 | 14 | 43 | 2 | GO:1900454 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 4.00e-04 | 167 | 43 | 4 | GO:0007043 | |
| GeneOntologyBiologicalProcess | cytokine production involved in immune response | 4.09e-04 | 168 | 43 | 4 | GO:0002367 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 4.37e-04 | 171 | 43 | 4 | GO:0050868 | |
| GeneOntologyBiologicalProcess | regulation of T cell tolerance induction | 4.38e-04 | 15 | 43 | 2 | GO:0002664 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 4.41e-04 | 309 | 43 | 5 | GO:0002703 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 4.83e-04 | 486 | 43 | 6 | GO:0007159 | |
| GeneOntologyBiologicalProcess | regulation of dendritic cell differentiation | 5.00e-04 | 16 | 43 | 2 | GO:2001198 | |
| GeneOntologyBiologicalProcess | cellular response to lipopolysaccharide | 5.03e-04 | 318 | 43 | 5 | GO:0071222 | |
| GeneOntologyBiologicalProcess | response to bacterium | 5.33e-04 | 916 | 43 | 8 | GO:0009617 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 5.34e-04 | 76 | 43 | 3 | GO:0042269 | |
| GeneOntologyBiologicalProcess | T cell tolerance induction | 5.66e-04 | 17 | 43 | 2 | GO:0002517 | |
| GeneOntologyBiologicalProcess | cellular response to molecule of bacterial origin | 6.11e-04 | 332 | 43 | 5 | GO:0071219 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 6.12e-04 | 187 | 43 | 4 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 6.20e-04 | 80 | 43 | 3 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | 6.76e-04 | 192 | 43 | 4 | GO:1903038 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 7.40e-04 | 85 | 43 | 3 | GO:0002762 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 8.05e-04 | 353 | 43 | 5 | GO:0010721 | |
| GeneOntologyBiologicalProcess | cellular response to biotic stimulus | 9.24e-04 | 364 | 43 | 5 | GO:0071216 | |
| GeneOntologyBiologicalProcess | regulation of CD8-positive, alpha-beta T cell activation | 9.55e-04 | 22 | 43 | 2 | GO:2001185 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 9.61e-04 | 211 | 43 | 4 | GO:0051250 | |
| GeneOntologyBiologicalProcess | regulation of tolerance induction | 1.04e-03 | 23 | 43 | 2 | GO:0002643 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic depression | 1.04e-03 | 23 | 43 | 2 | GO:1900452 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 1.10e-03 | 569 | 43 | 6 | GO:0034329 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 1.19e-03 | 385 | 43 | 5 | GO:0051251 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-10 production | 1.34e-03 | 26 | 43 | 2 | GO:0032693 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 1.36e-03 | 105 | 43 | 3 | GO:0042267 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.43e-03 | 235 | 43 | 4 | GO:0002822 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 1.44e-03 | 107 | 43 | 3 | GO:0042130 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 1.44e-03 | 27 | 43 | 2 | GO:1905874 | |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | 1.45e-03 | 236 | 43 | 4 | GO:0042129 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 1.52e-03 | 109 | 43 | 3 | GO:0002228 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 1.55e-03 | 240 | 43 | 4 | GO:0002695 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell differentiation | 1.55e-03 | 28 | 43 | 2 | GO:0043011 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 1.62e-03 | 614 | 43 | 6 | GO:0051249 | |
| GeneOntologyBiologicalProcess | cytokine production | 1.66e-03 | 1091 | 43 | 8 | GO:0001816 | |
| GeneOntologyBiologicalProcess | dendritic cell chemotaxis | 1.66e-03 | 29 | 43 | 2 | GO:0002407 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 1.69e-03 | 246 | 43 | 4 | GO:0045216 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 1.80e-03 | 423 | 43 | 5 | GO:0002696 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 1.82e-03 | 116 | 43 | 3 | GO:0045670 | |
| GeneOntologyBiologicalProcess | immune effector process | 1.84e-03 | 859 | 43 | 7 | GO:0002252 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 1.85e-03 | 252 | 43 | 4 | GO:0002819 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-2 production | 1.90e-03 | 31 | 43 | 2 | GO:0032703 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 1.90e-03 | 31 | 43 | 2 | GO:0045591 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 2.05e-03 | 875 | 43 | 7 | GO:0045596 | |
| GeneOntologyBiologicalProcess | decidualization | 2.15e-03 | 33 | 43 | 2 | GO:0046697 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 2.19e-03 | 264 | 43 | 4 | GO:0050866 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 2.20e-03 | 124 | 43 | 3 | GO:0050672 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 2.20e-03 | 124 | 43 | 3 | GO:0001910 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell mediated immunity | 2.28e-03 | 34 | 43 | 2 | GO:0002710 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 2.28e-03 | 447 | 43 | 5 | GO:1903037 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 2.30e-03 | 126 | 43 | 3 | GO:0032945 | |
| GeneOntologyBiologicalProcess | homeostasis of number of cells | 2.31e-03 | 448 | 43 | 5 | GO:0048872 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 2.33e-03 | 449 | 43 | 5 | GO:0050867 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 2.39e-03 | 663 | 43 | 6 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 2.41e-03 | 664 | 43 | 6 | GO:0099177 | |
| GeneOntologyCellularComponent | cell surface | ANTXR1 EPOR RAET1E EFNB1 SLAMF9 CDH1 CDH2 LILRB1 LILRB2 NOTCH4 L1CAM MXRA8 LILRB4 LAG3 TSPAN8 | 3.72e-09 | 1111 | 44 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.09e-06 | 519 | 44 | 9 | GO:0009897 | |
| GeneOntologyCellularComponent | side of membrane | ANTXR1 EPOR RAET1E SLAMF9 CDH1 LILRB1 LILRB2 L1CAM LILRB4 LAG3 | 1.07e-05 | 875 | 44 | 10 | GO:0098552 |
| GeneOntologyCellularComponent | anchoring junction | 2.74e-05 | 976 | 44 | 10 | GO:0070161 | |
| GeneOntologyCellularComponent | cell-cell junction | 2.81e-05 | 591 | 44 | 8 | GO:0005911 | |
| GeneOntologyCellularComponent | catenin complex | 4.14e-05 | 32 | 44 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 1.54e-04 | 9 | 44 | 2 | GO:0032998 | |
| GeneOntologyCellularComponent | plasma membrane raft | 2.56e-04 | 147 | 44 | 4 | GO:0044853 | |
| GeneOntologyCellularComponent | Fc receptor complex | 2.82e-04 | 12 | 44 | 2 | GO:0032997 | |
| GeneOntologyCellularComponent | apical junction complex | 3.37e-04 | 158 | 44 | 4 | GO:0043296 | |
| GeneOntologyCellularComponent | membrane raft | 9.45e-04 | 362 | 44 | 5 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 9.68e-04 | 364 | 44 | 5 | GO:0098857 | |
| GeneOntologyCellularComponent | adherens junction | 1.02e-03 | 212 | 44 | 4 | GO:0005912 | |
| GeneOntologyCellularComponent | caveola | 1.65e-03 | 111 | 44 | 3 | GO:0005901 | |
| GeneOntologyCellularComponent | bicellular tight junction | 2.64e-03 | 131 | 44 | 3 | GO:0005923 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 3.00e-03 | 137 | 44 | 3 | GO:0019897 | |
| GeneOntologyCellularComponent | tight junction | 3.12e-03 | 139 | 44 | 3 | GO:0070160 | |
| Domain | Cadherin_pro_dom | 5.46e-07 | 8 | 41 | 3 | IPR014868 | |
| Domain | Cadherin_pro | 5.46e-07 | 8 | 41 | 3 | SM01055 | |
| Domain | IG_LIKE | 9.24e-07 | 491 | 41 | 9 | PS50835 | |
| Domain | Ig-like_dom | 1.13e-06 | 503 | 41 | 9 | IPR007110 | |
| Domain | Ig-like_fold | EPOR ILDR1 SLAMF9 SIGIRR LILRB1 LILRB2 L1CAM MXRA8 LILRB4 LAG3 | 2.16e-06 | 706 | 41 | 10 | IPR013783 |
| Domain | IG | 3.10e-06 | 421 | 41 | 8 | SM00409 | |
| Domain | Ig_sub | 3.10e-06 | 421 | 41 | 8 | IPR003599 | |
| Domain | - | 1.07e-05 | 663 | 41 | 9 | 2.60.40.10 | |
| Domain | Cadherin_C | 2.18e-05 | 25 | 41 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 2.18e-05 | 25 | 41 | 3 | IPR000233 | |
| Domain | Catenin_binding_dom | 3.45e-05 | 29 | 41 | 3 | IPR027397 | |
| Domain | - | 3.45e-05 | 29 | 41 | 3 | 4.10.900.10 | |
| Domain | Cadherin_pro | 9.81e-05 | 7 | 41 | 2 | PF08758 | |
| Domain | IL-1_rcpt_fam | 2.55e-04 | 11 | 41 | 2 | IPR015621 | |
| Domain | Tetraspanin_CS | 9.62e-04 | 21 | 41 | 2 | IPR018503 | |
| Domain | TM4_1 | 1.48e-03 | 26 | 41 | 2 | PS00421 | |
| Domain | Cadherin_CS | 1.75e-03 | 109 | 41 | 3 | IPR020894 | |
| Domain | Cadherin | 1.94e-03 | 113 | 41 | 3 | PF00028 | |
| Domain | CADHERIN_1 | 1.94e-03 | 113 | 41 | 3 | PS00232 | |
| Domain | CADHERIN_2 | 1.99e-03 | 114 | 41 | 3 | PS50268 | |
| Domain | - | 1.99e-03 | 114 | 41 | 3 | 2.60.40.60 | |
| Domain | CA | 2.04e-03 | 115 | 41 | 3 | SM00112 | |
| Domain | Cadherin-like | 2.10e-03 | 116 | 41 | 3 | IPR015919 | |
| Domain | Cadherin | 2.20e-03 | 118 | 41 | 3 | IPR002126 | |
| Domain | Tetraspanin | 2.24e-03 | 32 | 41 | 2 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 2.24e-03 | 32 | 41 | 2 | IPR008952 | |
| Domain | Tetraspannin | 2.38e-03 | 33 | 41 | 2 | PF00335 | |
| Domain | Tetraspanin/Peripherin | 2.38e-03 | 33 | 41 | 2 | IPR018499 | |
| Domain | Cyt_P450_E_grp-I | 4.38e-03 | 45 | 41 | 2 | IPR002401 | |
| Domain | Cyt_P450_CS | 6.04e-03 | 53 | 41 | 2 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 6.95e-03 | 57 | 41 | 2 | PS00086 | |
| Domain | - | 7.19e-03 | 58 | 41 | 2 | 1.10.630.10 | |
| Domain | p450 | 7.19e-03 | 58 | 41 | 2 | PF00067 | |
| Domain | V-set | 7.62e-03 | 184 | 41 | 3 | PF07686 | |
| Domain | Cyt_P450 | 7.68e-03 | 60 | 41 | 2 | IPR001128 | |
| Domain | ig | 8.32e-03 | 190 | 41 | 3 | PF00047 | |
| Domain | Immunoglobulin | 8.32e-03 | 190 | 41 | 3 | IPR013151 | |
| Domain | Ig_V-set | 9.43e-03 | 199 | 41 | 3 | IPR013106 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 4.57e-05 | 190 | 30 | 5 | M8240 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.72e-04 | 133 | 30 | 4 | M16476 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 2.48e-04 | 58 | 30 | 3 | M11980 | |
| Pathway | REACTOME_FATTY_ACIDS | 4.52e-04 | 15 | 30 | 2 | M27126 | |
| Pathway | REACTOME_FATTY_ACIDS | 6.56e-04 | 18 | 30 | 2 | MM14841 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 7.32e-04 | 19 | 30 | 2 | M39370 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 9.02e-04 | 90 | 30 | 3 | M820 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.12e-03 | 97 | 30 | 3 | MM15926 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.15e-03 | 98 | 30 | 3 | M39830 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.26e-03 | 101 | 30 | 3 | M39448 | |
| Pubmed | Cadherins and tissue formation: integrating adhesion and signaling. | 1.89e-09 | 3 | 44 | 3 | 10333730 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 20204300 | ||
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 32341236 | ||
| Pubmed | Systematic analysis of E-, N- and P-cadherin expression in mouse eye development. | 1.89e-09 | 3 | 44 | 3 | 12126948 | |
| Pubmed | 1.89e-09 | 3 | 44 | 3 | 27223886 | ||
| Pubmed | 4.01e-09 | 16 | 44 | 4 | 18224708 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 11491530 | ||
| Pubmed | 7.55e-09 | 4 | 44 | 3 | 9015265 | ||
| Pubmed | Beyond E-cadherin: roles of other cadherin superfamily members in cancer. | 1.89e-08 | 5 | 44 | 3 | 24442140 | |
| Pubmed | HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. | 1.89e-08 | 5 | 44 | 3 | 15670976 | |
| Pubmed | Cloning and expression analysis of a novel mesodermally expressed cadherin. | 1.89e-08 | 5 | 44 | 3 | 7750649 | |
| Pubmed | 1.89e-08 | 5 | 44 | 3 | 38264972 | ||
| Pubmed | von Willebrand factor D and EGF domains regulate ameloblast differentiation and enamel formation. | 3.77e-08 | 6 | 44 | 3 | 34957547 | |
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 1427864 | ||
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 9079806 | ||
| Pubmed | 3.77e-08 | 6 | 44 | 3 | 9226036 | ||
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 8879495 | ||
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 17998301 | ||
| Pubmed | Genetic dissection of cadherin function during nephrogenesis. | 6.59e-08 | 7 | 44 | 3 | 11839813 | |
| Pubmed | Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. | 6.59e-08 | 7 | 44 | 3 | 19658091 | |
| Pubmed | 6.59e-08 | 7 | 44 | 3 | 9226037 | ||
| Pubmed | 1.05e-07 | 8 | 44 | 3 | 9548455 | ||
| Pubmed | 1.05e-07 | 8 | 44 | 3 | 7750641 | ||
| Pubmed | Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. | 2.25e-07 | 10 | 44 | 3 | 18802077 | |
| Pubmed | 3.10e-07 | 11 | 44 | 3 | 31835801 | ||
| Pubmed | 3.82e-07 | 47 | 44 | 4 | 24357327 | ||
| Pubmed | 5.36e-07 | 13 | 44 | 3 | 9615235 | ||
| Pubmed | 8.50e-07 | 15 | 44 | 3 | 33833667 | ||
| Pubmed | 8.50e-07 | 15 | 44 | 3 | 11032855 | ||
| Pubmed | 8.50e-07 | 15 | 44 | 3 | 30735538 | ||
| Pubmed | Cadherin expression in the developing mouse olfactory system. | 1.05e-06 | 16 | 44 | 3 | 17278136 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 24914828 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 10707907 | ||
| Pubmed | Dimeric states of neural- and epithelial-cadherins are distinguished by the rate of disassembly. | 1.56e-06 | 2 | 44 | 2 | 21375242 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 28218910 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 23955630 | ||
| Pubmed | Structural and energetic determinants of adhesive binding specificity in type I cadherins. | 1.56e-06 | 2 | 44 | 2 | 25253890 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22912891 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 21990317 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22664025 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 14559901 | ||
| Pubmed | Rescuing the N-cadherin knockout by cardiac-specific expression of N- or E-cadherin. | 1.56e-06 | 2 | 44 | 2 | 11171330 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 32918786 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 12390682 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 30829665 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 29734166 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 19535644 | ||
| Pubmed | Modulation of E-Cadherin and N-Cadherin by ovarian steroids and embryonic stimuli. | 1.56e-06 | 2 | 44 | 2 | 34710830 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 21300292 | ||
| Pubmed | The role of E and N-cadherin in the postoperative course of gonadotroph pituitary tumours. | 1.56e-06 | 2 | 44 | 2 | 30051197 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 3539943 | ||
| Pubmed | Cadherin-mediated cell sorting not determined by binding or adhesion specificity. | 1.56e-06 | 2 | 44 | 2 | 11790800 | |
| Pubmed | Prognostic significance of E-cadherin and N-cadherin expression in Gliomas. | 1.56e-06 | 2 | 44 | 2 | 28851312 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 20051668 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 14675278 | ||
| Pubmed | Expression of E- and P-cadherin during tooth morphogenesis and cytodifferentiation of ameloblasts. | 1.56e-06 | 2 | 44 | 2 | 9682977 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 3428270 | ||
| Pubmed | Genetic diversity of the LILRB1 and LILRB2 coding regions in an admixed Brazilian population sample. | 1.56e-06 | 2 | 44 | 2 | 35754199 | |
| Pubmed | [Cadherins E and P expression in the molecular types of breast cancer]. | 1.56e-06 | 2 | 44 | 2 | 26299056 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 7781895 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 24636838 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 21922637 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22072429 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 25607384 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 17923119 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 33433407 | ||
| Pubmed | N- and E-cadherin expression in human ovarian and urogenital duct development. | 1.56e-06 | 2 | 44 | 2 | 19324354 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 20190754 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 28628116 | ||
| Pubmed | Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma. | 1.56e-06 | 2 | 44 | 2 | 18801083 | |
| Pubmed | Differential expression of N-cadherin and E-cadherin in normal human tissues. | 1.56e-06 | 2 | 44 | 2 | 16819153 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 33979097 | ||
| Pubmed | Induction of antigen-specific human T suppressor cells by membrane and soluble ILT3. | 1.56e-06 | 2 | 44 | 2 | 23018130 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 12057916 | ||
| Pubmed | ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms. | 1.56e-06 | 2 | 44 | 2 | 38393969 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 19010139 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 15153430 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 9259559 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 12021924 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 23039892 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 25551576 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 7743137 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 19860908 | ||
| Pubmed | Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas. | 1.56e-06 | 2 | 44 | 2 | 16377805 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22490896 | ||
| Pubmed | E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements. | 1.56e-06 | 2 | 44 | 2 | 32572153 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 19919954 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 30982971 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 36010583 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 30006753 | ||
| Pubmed | Molecular design principles underlying β-strand swapping in the adhesive dimerization of cadherins. | 1.56e-06 | 2 | 44 | 2 | 21572446 | |
| Pubmed | Regulation of E- and P-cadherin expression correlated with melanocyte migration and diversification. | 1.56e-06 | 2 | 44 | 2 | 10545227 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 15713751 | ||
| Pubmed | Switch of cadherin expression as a diagnostic tool for Leydig cell tumours. | 1.56e-06 | 2 | 44 | 2 | 23398382 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22767507 | ||
| Pubmed | E-cadherin can replace N-cadherin during secretory-stage enamel development. | 1.56e-06 | 2 | 44 | 2 | 25014356 | |
| Pubmed | Differential spatiotemporal expression of E- and P-cadherin during mouse tooth development. | 1.56e-06 | 2 | 44 | 2 | 8619966 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 20451421 | ||
| Pubmed | Differential Expression of E-Cadherin and P-Cadherin in Breast Cancer Molecular Subtypes. | 1.56e-06 | 2 | 44 | 2 | 32988879 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 11875462 | ||
| Interaction | EVA1B interactions | 1.20e-05 | 68 | 42 | 4 | int:EVA1B | |
| Cytoband | 19q13.4 | 6.17e-05 | 79 | 44 | 3 | 19q13.4 | |
| GeneFamily | CD molecules|Type I classical cadherins | 5.02e-08 | 5 | 32 | 3 | 1185 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 5.02e-08 | 5 | 32 | 3 | 1182 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.65e-06 | 394 | 32 | 7 | 471 | |
| GeneFamily | Ferlin family | 4.53e-05 | 6 | 32 | 2 | 828 | |
| GeneFamily | CD molecules|Tetraspanins | 1.55e-03 | 33 | 32 | 2 | 768 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | ANTXR1 MYOF CXCL16 SLAMF9 MFRP CDH3 LILRB1 LILRB2 TMEM245 ACP2 L1CAM MXRA8 LILRB4 | 1.47e-07 | 1316 | 44 | 13 | MM1052 |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN | 1.02e-06 | 200 | 44 | 6 | M7508 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | ANTXR1 MYOF CXCL16 SLAMF9 MFRP CDH3 TMEM245 ACP2 L1CAM MXRA8 LILRB4 | 4.68e-06 | 1242 | 44 | 11 | M1920 |
| Coexpression | GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 1.95e-05 | 197 | 44 | 5 | M8672 | |
| Coexpression | GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP | 1.95e-05 | 197 | 44 | 5 | M8676 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN | 1.95e-05 | 197 | 44 | 5 | M8686 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP | 2.10e-05 | 200 | 44 | 5 | M385 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN | 2.10e-05 | 200 | 44 | 5 | M5156 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN | 2.10e-05 | 200 | 44 | 5 | M8682 | |
| Coexpression | MANALO_HYPOXIA_UP | 2.36e-05 | 205 | 44 | 5 | M259 | |
| Coexpression | AIZARANI_LIVER_C6_KUPFFER_CELLS_2 | 3.93e-05 | 228 | 44 | 5 | M39110 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS | 4.31e-05 | 116 | 44 | 4 | M40251 | |
| Coexpression | NADELLA_PRKAR1A_TARGETS_UP | 9.84e-05 | 9 | 44 | 2 | MM1230 | |
| Coexpression | NADELLA_PRKAR1A_TARGETS_UP | 9.84e-05 | 9 | 44 | 2 | M1790 | |
| Coexpression | AIZARANI_LIVER_C13_LSECS_2 | 1.09e-04 | 283 | 44 | 5 | M39117 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | 1.48e-04 | 302 | 44 | 5 | MM1046 | |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 1.54e-04 | 161 | 44 | 4 | M11857 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_MATURE_CELL | 1.85e-04 | 317 | 44 | 5 | MM1163 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | 1.89e-04 | 973 | 44 | 8 | M41080 | |
| Coexpression | WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP | 2.12e-04 | 13 | 44 | 2 | MM530 | |
| Coexpression | AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1 | 2.95e-04 | 191 | 44 | 4 | M39108 | |
| Coexpression | GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP | 3.13e-04 | 194 | 44 | 4 | M4152 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN | 3.52e-04 | 200 | 44 | 4 | M4616 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN | 3.52e-04 | 200 | 44 | 4 | M9328 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN | 3.52e-04 | 200 | 44 | 4 | M5228 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP | 3.52e-04 | 200 | 44 | 4 | M10032 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP | 3.52e-04 | 200 | 44 | 4 | M7159 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP | 3.52e-04 | 200 | 44 | 4 | M7430 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL | 4.10e-04 | 584 | 44 | 6 | M45668 | |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP | 4.11e-04 | 377 | 44 | 5 | M40997 | |
| Coexpression | SOUCEK_MYC_TARGETS | 4.62e-04 | 19 | 44 | 2 | MM1252 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_1000 | TMEM154 MYOF CXCL16 ILDR1 CYP2B6 BACE2 CDH1 FER1L4 L1CAM TSPAN8 | 9.97e-07 | 736 | 41 | 10 | gudmap_developingLowerUrinaryTract_adult_ureter_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#3_top-relative-expression-ranked_500 | 2.20e-06 | 110 | 41 | 5 | gudmap_developingLowerUrinaryTract_adult_ureter_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.85e-06 | 209 | 41 | 6 | gudmap_developingLowerUrinaryTract_adult_ureter_1000_k3 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K0 | 6.74e-06 | 711 | 41 | 9 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K0 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#5_top-relative-expression-ranked_500 | 1.18e-05 | 73 | 41 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_500 | 3.49e-05 | 96 | 41 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.04e-05 | 218 | 41 | 5 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_500 | 7.55e-05 | 373 | 41 | 6 | gudmap_developingLowerUrinaryTract_adult_ureter_500 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | 8.92e-05 | 987 | 41 | 9 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_1000 | 8.92e-05 | 987 | 41 | 9 | PCBC_ctl_SmallAirwayEpithel_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_top-relative-expression-ranked_1000 | 1.02e-04 | 778 | 41 | 8 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K4 | TMEM154 TRPM4 MYOF RAET1E ILDR1 BACE2 FER1L4 L1CAM VTI1B TSPAN8 | 1.76e-04 | 1337 | 41 | 10 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.95e-04 | 280 | 41 | 5 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_500 | 2.01e-04 | 59 | 41 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#5_top-relative-expression-ranked_200 | 2.22e-04 | 61 | 41 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_200_k5 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 2.23e-04 | 455 | 41 | 6 | GSM777055_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_200 | 2.53e-04 | 160 | 41 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.59e-04 | 161 | 41 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.05e-04 | 168 | 41 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_500 | 3.54e-04 | 496 | 41 | 6 | PCBC_ctl_BronchioEpithel_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_500 | 4.10e-04 | 75 | 41 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_1000 | 4.85e-04 | 978 | 41 | 8 | PCBC_ctl_CardioEndothel_1000 | |
| CoexpressionAtlas | appendix | 4.86e-04 | 190 | 41 | 4 | appendix | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#3_top-relative-expression-ranked_100 | 4.86e-04 | 17 | 41 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_100_k3 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2 | 5.13e-04 | 81 | 41 | 3 | GSM854271_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_1000 | 5.26e-04 | 990 | 41 | 8 | PCBC_ctl_BronchioEpithel_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#2_top-relative-expression-ranked_500 | 5.32e-04 | 82 | 41 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#5_top-relative-expression-ranked_500 | 5.32e-04 | 82 | 41 | 3 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k5 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang+103-11b+.SLN, MHCIIhi CD11c+ Langerin+ CD103- CD11b+, Lymph Node, avg-3 | 5.51e-04 | 83 | 41 | 3 | GSM538271_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 5.91e-04 | 85 | 41 | 3 | GSM605843_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 6.12e-04 | 86 | 41 | 3 | GSM605840_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3 | 6.33e-04 | 87 | 41 | 3 | GSM854299_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2 | 6.33e-04 | 87 | 41 | 3 | GSM854297_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | 6.64e-04 | 780 | 41 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.LuLN, MHCII+ CD11c+ CD8- CD11b+ CD103-, Lymph Node, avg-3 | 6.66e-04 | 366 | 41 | 5 | GSM854255_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 6.79e-04 | 783 | 41 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 7.21e-04 | 91 | 41 | 3 | GSM538280_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103- F4/80+, Small Intestine, avg-7 | 7.98e-04 | 381 | 41 | 5 | GSM854262_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_top-relative-expression-ranked_500 | 8.76e-04 | 389 | 41 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_500 | 8.96e-04 | 391 | 41 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_500 | |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | 1.01e-03 | 402 | 41 | 5 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.02e-03 | 232 | 41 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k3 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_CollectIng Duct_2500_K2 | 1.04e-03 | 609 | 41 | 6 | gudmap_RNAseq_e15.5_CollectIng Duct_2500_K2 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.IEL, CD8a+ CD8b- TCRgd+ Vg5- CD44lo, Small Intestine, avg-3 | 1.05e-03 | 405 | 41 | 5 | GSM605811_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-1 | 1.07e-03 | 407 | 41 | 5 | GSM854287_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#2_top-relative-expression-ranked_500 | 1.09e-03 | 105 | 41 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k2 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44lo, Small Intestine, avg-3 | 1.17e-03 | 415 | 41 | 5 | GSM605805_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.19e-03 | 108 | 41 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.63e-08 | 188 | 43 | 6 | 3e94d105ca96ceb5fdcca39a8050217913bc02da | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.18e-08 | 194 | 43 | 6 | b133d3d198360269cc449a75d34c29be377d91e0 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.27e-08 | 195 | 43 | 6 | 4e9513a7ea69fa9fc8e9ff2da8ef3f44e8fdc70d | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.27e-08 | 195 | 43 | 6 | a25a342380e258b784227f7298f609ccaa1f9ce7 | |
| ToppCell | Influenza_Severe-Non-classical_Monocyte|World / Disease group and Cell class | 3.37e-08 | 196 | 43 | 6 | 8ef9810ee99082a9c803c7ecad6ceb5710d16b54 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.58e-08 | 198 | 43 | 6 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.80e-08 | 200 | 43 | 6 | 52f2a97af2d77dd068b19531dad1b3fba2601e90 | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 3.80e-08 | 200 | 43 | 6 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 3.80e-08 | 200 | 43 | 6 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | Monocytes-IFN-activated_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.40e-07 | 171 | 43 | 5 | df1b631618839bee4a18a2ba9c730321e5015f36 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.78e-07 | 173 | 43 | 5 | 2cba41c3d9d3076f703115d19729073a3ac3feb6 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.78e-07 | 173 | 43 | 5 | 11d69a4ab4a87b8820cd3bd204de8c4124450a90 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 6.98e-07 | 174 | 43 | 5 | 268abfc4d53a3ba3931dbcafffef09a72ea0edfa | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.98e-07 | 174 | 43 | 5 | 96f1d025af3a5bf616926a558885d196c3cd2709 | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.38e-07 | 176 | 43 | 5 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | 7.38e-07 | 176 | 43 | 5 | 72a3bbab0540ae3e3c94b9573cdb9298a024dbc4 | |
| ToppCell | 15-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 7.81e-07 | 178 | 43 | 5 | f0557920b9b3e7c4f39938d1b524aa58711af4d2 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.03e-07 | 179 | 43 | 5 | ce95b601bf17ae8167d382a105384b9e65e9407f | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.25e-07 | 180 | 43 | 5 | ba4c1fb55e8f1095bea6968417fefcf5f700926b | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.71e-07 | 182 | 43 | 5 | 1fb9bdf2e9f0a9c230f109b471672f9c31e27c82 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-07 | 184 | 43 | 5 | ba260f8a2e6e510141a6b9c458eb0040acff0352 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.70e-07 | 186 | 43 | 5 | bec4767eaca28e41da373274704895eba75063e2 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 9.96e-07 | 187 | 43 | 5 | c20689022569640ebc4a878e3fe146b86fe9b386 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 9.96e-07 | 187 | 43 | 5 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-06 | 188 | 43 | 5 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 1.02e-06 | 188 | 43 | 5 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 1.02e-06 | 188 | 43 | 5 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 188 | 43 | 5 | b40146ed0af022422e6526116e5897c676ed9d71 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 1.05e-06 | 189 | 43 | 5 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.08e-06 | 190 | 43 | 5 | 47513757e0059e8370e49672a577f25ca842e98c | |
| ToppCell | Influenza_Severe-Non-classical_Monocyte|Influenza_Severe / Disease group and Cell class | 1.10e-06 | 191 | 43 | 5 | 197edf6feb1cfc71d88e532d74f77305a42a3486 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-06 | 191 | 43 | 5 | 1e668d67bc254ea15518e2c7a029a61087609b7a | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.16e-06 | 193 | 43 | 5 | 7839040e703877ef321494ad8926a8604729ceda | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | 536b277d90070c4571c592a3c6323b4bf4819f67 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | 5b30bbb354c69f684a1c8d2c68e9b3424d759e8d | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 193 | 43 | 5 | 0499611c21d283321ef6dd24add154dea48da1b7 | |
| ToppCell | severe-Myeloid-CD16_Monocytes|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.19e-06 | 194 | 43 | 5 | 1b33248b8a7cb914783bcf9e6a80481b4db7e0e8 | |
| ToppCell | Monocytes-C1QA+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.19e-06 | 194 | 43 | 5 | 3e104e85574894c04791252d466d438fc809dde3 | |
| ToppCell | severe_influenza-Non-classical_Monocyte|severe_influenza / disease group, cell group and cell class (v2) | 1.19e-06 | 194 | 43 | 5 | 7630e223666fb65743e21e045478f687dd739a54 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class | 1.19e-06 | 194 | 43 | 5 | d70b9039fd2fef3e4be086513b94fb7e9bc1f670 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 1.19e-06 | 194 | 43 | 5 | 5151546812678ae85cb22224084d27b29e3c4724 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.22e-06 | 195 | 43 | 5 | eb809331557f8c40de45b1208cbc49b621930a4b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-06 | 195 | 43 | 5 | 9168267a799bbd4111b1227754ab8173ac1a4714 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.25e-06 | 196 | 43 | 5 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | severe_COVID-19-Non-classical_Monocyte|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.25e-06 | 196 | 43 | 5 | 34c1c74cad5e23196e86cfd6f19c836fe57b2264 | |
| ToppCell | remission-Non-classical_Monocyte|remission / disease stage, cell group and cell class | 1.25e-06 | 196 | 43 | 5 | 049d995986c20ce066bd64fcc2d2f1c2f8899883 | |
| ToppCell | 11.5-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 1.25e-06 | 196 | 43 | 5 | 2648d64b0e7b59ae78182d55f32699ceea37ff8d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-06 | 196 | 43 | 5 | 51fc8bb9a806f8fbf78d5d80d535f1068a9770c2 | |
| ToppCell | critical-Epithelial-Secretory|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.25e-06 | 196 | 43 | 5 | 7da687eb983a54c28ee990424cc52e01caf5f4aa | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 1.25e-06 | 196 | 43 | 5 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-06 | 197 | 43 | 5 | 759f26753f76af3ae8d8527c4d221206245a3d45 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-06 | 197 | 43 | 5 | 09a2c0c0f9c2442743414236c2d5c1f27be66e4c | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 1.29e-06 | 197 | 43 | 5 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 1.29e-06 | 197 | 43 | 5 | 67f19dd30adb03300f04219d0295bc1c1788f626 | |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.29e-06 | 197 | 43 | 5 | 368644260f70895052a1d71171a9d882315354dd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-06 | 197 | 43 | 5 | 989eaf7ecef8683e3ec6ec024fd193a2f5861b26 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-06 | 197 | 43 | 5 | d9d58c2fe40d9b5b9031fb7a71525a535927effe | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.29e-06 | 197 | 43 | 5 | 1463522df1b6358cbe3b5022a3e153878e9c9e43 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.29e-06 | 197 | 43 | 5 | 46d8c7e9b3aff70bc58894282d0ec9e87d37235f | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|COVID-19 / Condition, Lineage and Cell class | 1.29e-06 | 197 | 43 | 5 | 4a9c61b37c938bb26929593007d713382ae1eb79 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.29e-06 | 197 | 43 | 5 | 1a82e0e74fc5fd71c490d98e8813d719b0b81aa6 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-CX3CR1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.29e-06 | 197 | 43 | 5 | 0e231b12881ab1f0f08040f248ea2e6fba34bc2f | |
| ToppCell | remission-Non-classical_Monocyte|World / disease stage, cell group and cell class | 1.32e-06 | 198 | 43 | 5 | 1c170655070acca00520b7cf9c510a04c0a90a8f | |
| ToppCell | severe_influenza-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.32e-06 | 198 | 43 | 5 | 790ee20abc9666b8095675b0d445c0914ee70ea3 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.32e-06 | 198 | 43 | 5 | 8449934e20bb2a34079fb642cae0d4647b9efe51 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.32e-06 | 198 | 43 | 5 | 11b0d021114df73a539b04f76dd7c63f1fdbdf4f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-06 | 198 | 43 | 5 | be038619157aeaa7a57ebd66392de940df4f8127 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.35e-06 | 199 | 43 | 5 | 362da30f3a88b003103796c56782be0dfd6705a9 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-06 | 199 | 43 | 5 | 29dc81a98bd3fa86380cc642a23e9084fec05cab | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.35e-06 | 199 | 43 | 5 | 7dde5c02fcae64cd2d68f607500f2a46b97851fd | |
| ToppCell | VE-granulo2|VE / Condition, Cell_class and T cell subcluster | 1.35e-06 | 199 | 43 | 5 | 05b47fdc01eccee0eaf4c781eeff93c47fe0533e | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.35e-06 | 199 | 43 | 5 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-06 | 199 | 43 | 5 | c4fc638a8dad3a9b77634e8912a9326c8a2f11f5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.35e-06 | 199 | 43 | 5 | 742d17529ff5b4ac294f4af6b683e126c2781d9f | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-06 | 199 | 43 | 5 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM1|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.35e-06 | 199 | 43 | 5 | 8895332f0026e59cd19f41de0ef014f7b2af74e1 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.35e-06 | 199 | 43 | 5 | 84879280851380e5bfe6bd48b6bbf57aedf6e003 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-06 | 199 | 43 | 5 | 2c12821cd0823acf31bdf16f4e0d39d8ebed2479 | |
| ToppCell | VE-granulo2-|VE / Condition, Cell_class and T cell subcluster | 1.35e-06 | 199 | 43 | 5 | 455e92047201ddd0c29a437a838e5fa135de7995 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-06 | 199 | 43 | 5 | 18b6087863fda22e3e2a2167e7daeb347df1d95b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-06 | 199 | 43 | 5 | 697a9a58c0cdb77222700d029873355d37f6ab28 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-06 | 199 | 43 | 5 | 6783d571d28eac891fcc70380f176b53f35c88ba | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.39e-06 | 200 | 43 | 5 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | BAL-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-06 | 200 | 43 | 5 | bb246c630b2fde1633b28838a5f087fdfb4bc4a5 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / Condition, Lineage and Cell class | 1.39e-06 | 200 | 43 | 5 | 4c9e936b5e100c1a3ef10ea262febccf8226df9f | |
| ToppCell | Caecum-Macrophage-Macrophage|Caecum / Region, Cell class and subclass | 1.39e-06 | 200 | 43 | 5 | 99dcf07b17ecf90d596f3b8a12d5b7aae2a351d5 | |
| ToppCell | mLN-(6)_Macrophage-(61)_LYVE1_Macrophage|mLN / shred on region, Cell_type, and subtype | 1.39e-06 | 200 | 43 | 5 | a20f5ec61d492d8a2adf695ec304b5d57296aa8f | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|mLN / Region, Cell class and subclass | 1.39e-06 | 200 | 43 | 5 | 89cf739a3c2f5d30e547404f2f2ec6500cd1d65d | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-CD16+_Monocyte|Influenza_Severe / Disease, condition lineage and cell class | 1.39e-06 | 200 | 43 | 5 | 1efdcfcd86e99fbe03db19a2a5ab10808eec282d | |
| ToppCell | Caecum-(6)_Macrophage-(60)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.39e-06 | 200 | 43 | 5 | 67b6cdeb07ffc5c9af7a3e738dd31256cf391e98 | |
| ToppCell | BAL-Severe-Myeloid-MoAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-06 | 200 | 43 | 5 | 43ec6732cc255d533170ebf95d282e503606dcc6 | |
| ToppCell | Severe_COVID-19-Myeloid|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.39e-06 | 200 | 43 | 5 | 5a199f2a32dd2cb3a2f2d6ee73798114786a37a2 | |
| ToppCell | BAL-Severe-Myeloid-MoAM|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-06 | 200 | 43 | 5 | 60bf9f9d4899245463707016e51cd7243f6405b4 | |
| ToppCell | BAL-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-06 | 200 | 43 | 5 | 9bc2e86d84cc7e328950e7273014de5a5d2549c4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-06 | 200 | 43 | 5 | 97f261d56bc6c55683eb4c42670d00b9a6992a26 | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.39e-06 | 200 | 43 | 5 | 631550dc34bcb605ab726645f4024d7828bb7975 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 149 | 43 | 4 | dede8ffc14ce63e0058bde1394b31bb4088996b3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 149 | 43 | 4 | 97015942c4ac797e1c12a1673cd147c10450b15a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 150 | 43 | 4 | 65ad642cd237ba0db4bde7371533884db2fa0aae | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 150 | 43 | 4 | d44c02402e59a45e40b8fffbe71284032b5e7c92 | |
| Computational | Adhesion molecules. | 2.79e-05 | 141 | 28 | 5 | MODULE_122 | |
| Computational | Genes in the cancer module 342. | 1.98e-04 | 213 | 28 | 5 | MODULE_342 | |
| Computational | Genes in the cancer module 119. | 4.80e-04 | 143 | 28 | 4 | MODULE_119 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 3.94e-05 | 7 | 41 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 1.03e-04 | 11 | 41 | 2 | EFO_0008209 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 1.96e-04 | 15 | 41 | 2 | EFO_0008208 | |
| Disease | Nerve Degeneration | 2.12e-04 | 83 | 41 | 3 | C0027746 | |
| Disease | Agouti-related protein measurement | 6.47e-04 | 27 | 41 | 2 | EFO_0008016 | |
| Disease | colorectal cancer | 1.44e-03 | 604 | 41 | 5 | MONDO_0005575 | |
| Disease | Thyroid carcinoma | 1.72e-03 | 44 | 41 | 2 | C0549473 | |
| Disease | Malignant neoplasm of salivary gland | 1.80e-03 | 45 | 41 | 2 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 1.96e-03 | 47 | 41 | 2 | C0036095 | |
| Disease | Neoplasm Invasiveness | 2.14e-03 | 184 | 41 | 3 | C0027626 | |
| Disease | depressive disorder (biomarker_via_orthology) | 2.39e-03 | 52 | 41 | 2 | DOID:1596 (biomarker_via_orthology) | |
| Disease | episodic memory | 2.39e-03 | 52 | 41 | 2 | EFO_0004333 | |
| Disease | polyp of colon | 2.77e-03 | 56 | 41 | 2 | MONDO_0021400 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AILLVLIVLLLLPFR | 481 | Q9Y5Z0 | |
| LLFLALLTGLLLLLV | 6 | P20813 | |
| SILAIALLILFLLLA | 321 | Q9H6X2 | |
| VLLLLLLLLLVYLTQ | 11 | Q9H2A7 | |
| LLLLLLLGSIILALL | 156 | Q16671 | |
| VRLLLFLLLLLIALE | 11 | Q8TD07 | |
| LLLLLLGLLVAIILA | 76 | Q9BY79 | |
| VVSILLLSLLLFLLL | 266 | Q8NHJ6 | |
| LVLLLLVLLTVFLLL | 1761 | A9Z1Z3 | |
| VIFIILGALLLLLLI | 171 | Q86SU0 | |
| VAVVLLLLLLLLLFL | 466 | Q8N423 | |
| FVSAIILLLLVLLIL | 1126 | P32004 | |
| ILLLLVLLILCFIKR | 1131 | P32004 | |
| LLFLILGVLSLLLLV | 451 | P18627 | |
| IFLLTILAALALLVL | 316 | A8MVW0 | |
| ILFLLIVLLLTVLFR | 391 | P11117 | |
| LLFVLLLLLIILTES | 511 | Q7Z6J6 | |
| VTSLLILLLLLIKAA | 21 | Q5TCH4 | |
| FLLIIIFLTVLLLKL | 251 | P98172 | |
| LILTLSLILVVILVL | 251 | P19235 | |
| LLFLLLVLLLLVRKK | 666 | P22223 | |
| IAILLCIIILLILVL | 726 | P19022 | |
| GILALLILILLLLLF | 716 | P12830 | |
| LLLLIPFLILLRKLI | 171 | Q8NGH6 | |
| KAIILVTILLLLRLV | 16 | P59551 | |
| SLLILVVFLLLLVLT | 131 | Q5T9Z0 | |
| LVAVILLLLLLLLLF | 466 | Q8NHL6 | |
| LLLLLLLLLFLILRH | 471 | Q8NHL6 | |
| VVLLLLLLLLLATGL | 36 | Q14761 | |
| LLVLLALLLAALLYV | 126 | Q6IA17 | |
| LLAFLLLLLIIALQR | 51 | A2A2V5 | |
| LLLLLLLLLLLCVSV | 6 | Q99466 | |
| LLIVLLSYLLILVAI | 211 | Q8NH51 | |
| SLVRLLLLVLILLVL | 6 | P07998 | |
| LLVLLLLLFIIVFIL | 151 | Q5JXX7 | |
| IILLILILVLFSSLS | 916 | Q5TF21 | |
| LLAKGLLIFLLLVIL | 236 | Q96A28 | |
| IFLLVIGTLLLALLL | 466 | Q9H330 | |
| LIPLILLVLLLLSVV | 81 | Q6P9G4 | |
| KLLLSIIILLELAIL | 206 | Q9UEU0 | |
| ILLLLALLTLIISVT | 41 | O00124 | |
| VLLLVIFLLVANILL | 1021 | Q8TD43 | |
| LLFFIGLLLILLLQV | 86 | P19075 | |
| LVILLAELILLILFF | 91 | O75954 | |
| YDVLLLLLLLVLLLQ | 301 | Q15049 | |
| LATLLLFILLLVTVL | 346 | Q9BRK3 | |
| LLFLLILLLFVAVLL | 2031 | Q9NZM1 |